Reuters logo
BRIEF-Hybio Pharmaceutical receives patent license in U.S.
September 12, 2017 / 2:07 AM / 13 days ago

BRIEF-Hybio Pharmaceutical receives patent license in U.S.

Sept 12(Reuters) - Hybio Pharmaceutical Co Ltd

* Says it received a patent license (No. US 9,637,517 B2), named METHOD FOR PREPARING EXENATIDE

Source text in Chinese: goo.gl/cK5Qt6

Further company coverage: (Beijing Headline News)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below